Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Feb;23(1):105-10.
doi: 10.1007/s10577-014-9456-2.

Developing de novo human artificial chromosomes in embryonic stem cells using HSV-1 amplicon technology

Affiliations
Review

Developing de novo human artificial chromosomes in embryonic stem cells using HSV-1 amplicon technology

Daniela Moralli et al. Chromosome Res. 2015 Feb.

Abstract

De novo artificial chromosomes expressing genes have been generated in human embryonic stem cells (hESc) and are maintained following differentiation into other cell types. Human artificial chromosomes (HAC) are small, functional, extrachromosomal elements, which behave as normal chromosomes in human cells. De novo HAC are generated following delivery of alpha satellite DNA into target cells. HAC are characterized by high levels of mitotic stability and are used as models to study centromere formation and chromosome organisation. They are successful and effective as gene expression vectors since they remain autonomous and can accommodate larger genes and regulatory regions for long-term expression studies in cells unlike other viral gene delivery vectors currently used. Transferring the essential DNA sequences for HAC formation intact across the cell membrane has been challenging for a number of years. A highly efficient delivery system based on HSV-1 amplicons has been used to target DNA directly to the ES cell nucleus and HAC stably generated in human embryonic stem cells (hESc) at high frequency. HAC were detected using an improved protocol for hESc chromosome harvesting, which consistently produced high-quality metaphase spreads that could routinely detect HAC in hESc. In tumour cells, the input DNA often integrated in the host chromosomes, but in the host ES genome, it remained intact. The hESc containing the HAC formed embryoid bodies, generated teratoma in mice, and differentiated into neuronal cells where the HAC were maintained. The HAC structure and chromatin composition was similar to the endogenous hESc chromosomes. This review will discuss the technological advances in HAC vector delivery using HSV-1 amplicons and the improvements in the identification of de novo HAC in hESc.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Assembly of HSV-1 amplicon HAC vectors. A large BAC, carrying alpha satellite and/or transgenes, is retrofitted with the HSV-1 necessary elements via LoxP-Cre recombination with a smaller plasmid carrying the HSV-1 origin of replication and packaging signal
Fig. 2
Fig. 2
Production of infectious particles. The HSV-1 amplicon HAC vector is transfected into helper cells along with the whole HSV-1 genome (lacking the ICP27 gene and the packaging signal) and a small plasmid expressing the essential HSV-1 protein ICP27. The cell assembles the HSV-1 capsids and packages the HSV-1 amplicon HAC vector
Fig. 3
Fig. 3
MFISH on HUES10 hESc metaphase spread, obtained with an improved chromosome harvesting procedure
Fig. 4
Fig. 4
FISH on HAC containing hESc. The metaphase spread has been hybridised with a 17alpha satellite probe (red signal) identifying the HAC (arrow), along with the endogenous chromosomes 17. The small inset show the DAPI staining of the HAC, as a black and white picture

Similar articles

Cited by

References

    1. Baum C. Insertional mutagenesis in gene therapy and stem cell biology. Curr Opin Hematol. 2007;14:337–342. doi: 10.1097/MOH.0b013e3281900f01. - DOI - PubMed
    1. Bergmann JH, Martins NM, Larionov V, Masumoto H, Earnshaw WC. HACking the centromere chromatin code: insights from human artificial chromosomes. Chromosome Res. 2012;20:505–519. doi: 10.1007/s10577-012-9293-0. - DOI - PubMed
    1. Cowan CA, Klimanskaya I, McMahon J, Atienza J, Witmyer J, Zucker JP, Wang S, Morton CC, McMahon AP, Powers D, Melton DA. Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med. 2004;350:1353–1366. doi: 10.1056/NEJMsr040330. - DOI - PubMed
    1. Grimes BR, Monaco ZL. Artificial and engineered chromosomes: developments and prospects for gene therapy. Chromosoma. 2005;4:230–241. doi: 10.1007/s00412-005-0017-5. - DOI - PubMed
    1. Kouprina N, Tomilin AN, Masumoto H, Earnshaw WC, Larionov V. Human artificial chromosome-based gene delivery vectors for biomedicine and biotechnology. Expert Opin Drug Deliv. 2014;11:517–535. doi: 10.1517/17425247.2014.882314. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources